BioSpace News Archive

Black Diamond Therapeutics, Inc. today announced the appointment of Mark A. Velleca, M.D., Ph.D. to its Board of Directors.

Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera) a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, announces today that it will report second quarter 2021 financial results on Friday, August 13, 2021, prior to the market open.

Phathom Pharmaceuticals, Inc. today reported financial results for the second quarter of 2021 and provided an update on expected clinical and regulatory milestones.

LQT Therapeutics, Inc. (LQTT) a pharmaceutical company pioneering the development of precision therapies for genetic heart diseases, today announced the successful completion of a US$19 million Series A financing.

VERAXA Biotech GmbH, Heidelberg, and Indivumed GmbH, Hamburg, announced today their agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer.

Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the presentation of data highlighting the performance of its Solus Gold Embolization Device during a session on new embolization devices at the 2021 Global Embolization Symposium and Technologies (GEST) annual meeting on July 31st, 2021.

SymphonyRM, healthcare’s Next Best Action company, released the results of a study that reveals how COVID-19 impacted Americans’ expectations of their doctors today.

Mylab Discovery Solutions, India’s leading biotechnology company, has joined forces with the United States-based Hemex Health, a medical diagnostic device company focused on creating life-changing global health products, to develop next-generation diagnostic solutions for the Point-of-Care (POC) testing of coronavirus and other diseases.

Twist Bioscience Corporation today announced that Jim Thorburn, CFO of Twist Bioscience, and Patrick Finn, chief commercial officer, will host a fireside chat at the UBS Genomics 2.0 and Medtech Innovations Summit on August 11 th at 2:00 p.m. P.T. in Laguna Beach, California.

Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing codes by the Center of Medicare & Medicaid Services (CMS) in accordance with the Healthcare Common Procedure Coding System (HCPCS).